Sana Biotechnology SANA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's total liabilities?
- Sana Biotechnology (SANA) reported total liabilities of $254.35M in Q1 2026.
- How has Sana Biotechnology's total liabilities changed year-over-year?
- Sana Biotechnology's total liabilities increased by 7.6% year-over-year, from $236.39M to $254.35M.
- What is the long-term trend for Sana Biotechnology's total liabilities?
- Over 5 years (2020 to 2025), Sana Biotechnology's total liabilities has grown at a -3.0% compound annual growth rate (CAGR), from $298.58M to $256.01M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.